Across TCGA pan-cancer cohorts, UNC5C RNA is linked to patient survival in 23 of 34 cancer types, making it the most broadly survival-associated UNC5C data layer compared with 8 for mutation status and 2 for mass-spec protein.
The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher UNC5C RNA is associated with worse overall survival. In most high-consensus cancer types, elevated UNC5C expression acts as an unfavorable survival marker, although some lineages such as KIRC and LIHC show a favorable association.
BLCA, KIRP, and UVM are the cancer types where UNC5C RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.